Consequently, the aberrant activation of this HGF/c-MET signaling pathway promotes tumor cell proliferation and angiogenesis, inhibition of apoptosis, and EMT programming and is linked to an overall poor patient prognosis and survival rate [113, 120, 121]. The gene discussed is HGF; the disease is neoplasm.